{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:27:59Z","timestamp":1778232479065,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11845-017-1717-6","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:39:23Z","timestamp":1514954363000},"page":"789-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes"],"prefix":"10.1007","volume":"187","author":[{"given":"Claire","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran","family":"O\u2019Riain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"1717_CR1","unstructured":"Green AE, Garcia AA, Ahmed S (2014) Ovarian cancer. Available at: http:\/\/emedicine.medscape.com\/article\/255771-overview http:\/\/emedicine.medscap"},{"key":"1717_CR2","unstructured":"Ovarian Cancer Statistics. National Cancer Registry Ireland. Available at: www.ncri.ie"},{"issue":"4","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","volume":"189","author":"JS Barnholz-Sloan","year":"2003","unstructured":"Barnholz-Sloan JS, Schwartz AG, Qureshi F et al (2003) Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189(4):1120\u20131127. https:\/\/doi.org\/10.1067\/S0002-9378(03)00579-9","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","volume":"43","author":"WG McCluggage","year":"2011","unstructured":"McCluggage WG (2011) Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 43(5):420\u2013432. https:\/\/doi.org\/10.1097\/PAT.0b013e328348a6e7","journal-title":"Pathology"},{"issue":"5","key":"1717_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"LM Shih","year":"2004","unstructured":"Shih LM, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511\u20131518. https:\/\/doi.org\/10.1016\/S0002-9440(10)63708-X","journal-title":"Am J Pathol"},{"key":"1717_CR6","first-page":"461","volume":"93","author":"M Koshiyama","year":"2014","unstructured":"Koshiyama M, Matsumura N, Ikuo K (2014) Recent concepts of ovarian carcinogenesis: type I and type II. Biomed Res Int 93:461","journal-title":"Biomed Res Int"},{"key":"1717_CR7","unstructured":"Gross AL, Kurman RJ, Russell V, Shih LM, Visvanathan K (2010) Precursor lesions of high grade serous ovarian oarcinoma: morphological and molecular characteristics. J Oncol ID 126295"},{"key":"1717_CR8","doi-asserted-by":"publisher","unstructured":"Erickson BK, Connor MG, Landen CN (2013) The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol 209(5):409\u2013414. https:\/\/doi.org\/10.1016\/j.ajog.2013.04.019","DOI":"10.1016\/j.ajog.2013.04.019"},{"key":"1717_CR9","unstructured":"Clarke BA, Crum CP, Nucci MR et al Protocol for the examination of specimens from patients with carcinoma of the fallopian tube. College of American Pathologists. Based on AJCC\/UICC TNM, 7th edition, and FIGO 2006 Annual Report. Available at: http:\/\/www.cap.org"},{"issue":"8","key":"1717_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/IGC.0000000000000791","volume":"26","author":"C Poon","year":"2016","unstructured":"Poon C, Hyde S, Grant P, Newman M, Ireland Jenkin K (2016) Incidence and characteristics of unsuspected neoplasia discovered in high-risk women undergoing risk reductive bilateral salpingooophorectomy. Int J Gynecol Cancer 26(8):1415\u20131420. https:\/\/doi.org\/10.1097\/IGC.0000000000000791","journal-title":"Int J Gynecol Cancer"},{"key":"1717_CR11","unstructured":"National Cancer Institute (2014) Ovarian cancer screening (PDQ_). Available at: http:\/\/www.cancer.gov\/cancertopics\/pdq\/screening\/ovarian\/healthprofessional\/allpages"},{"issue":"10022","key":"1717_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ (2016) Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial. Lancet 387(10022):945\u2013956. https:\/\/doi.org\/10.1016\/S0140-6736(15)01224-6","journal-title":"Lancet"},{"issue":"7353","key":"1717_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research","year":"2011","unstructured":"Cancer Genome Atlas Research (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609\u2013615","journal-title":"Nature"},{"issue":"21","key":"1717_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, de Fazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, Friedlander M, Fox S, Bowtell D, Mitchell G (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30(21):2654\u20132663. https:\/\/doi.org\/10.1200\/JCO.2011.39.8545","journal-title":"J Clin Oncol"},{"key":"1717_CR15","doi-asserted-by":"publisher","unstructured":"Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. Br J Obstet Gynaecol 118(7):814\u2013824. https:\/\/doi.org\/10.1111\/j.1471-0528.2011.02920.x","DOI":"10.1111\/j.1471-0528.2011.02920.x"},{"issue":"5","key":"1717_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann LC, Lindor NM (2016) The role of risk reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5):454\u2013468. https:\/\/doi.org\/10.1056\/NEJMra1503523","journal-title":"N Engl J Med"},{"issue":"11","key":"1717_CR17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.mayocp.2016.08.002","volume":"91","author":"WA Rocca","year":"2016","unstructured":"Rocca WA, Gazzuola-Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, Stewart EA, Miller VM (2016) Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study. Mayo Clin Proc 91(11):1577\u20131589. https:\/\/doi.org\/10.1016\/j.mayocp.2016.08.002","journal-title":"Mayo Clin Proc"},{"key":"1717_CR18","unstructured":"NCCN Clinical practice guidelines in oncology. Genetic\/familial high risk assessment: breast and ovarian. Updated 7th December 2016. Available at: http:\/\/www.nccn.org"},{"key":"1717_CR19","unstructured":"SIGN Guidance. Number 135: management of epithelial ovarian cancer. Updated November 2013. Available at: http:\/\/www.sign.ac.uk"},{"key":"1717_CR20","doi-asserted-by":"crossref","unstructured":"Domchek S, Friebel T, Neuhausen S, et al. (2011) Is hormone replacement therapy (HRT) following risk-reducing salphingo-oophorectomy (RRSO) in BRCA 1 (B1) and BRCA 2 (B2) mutation carriers associated with an increased risk of breast cancer? J Clin Oncol 29 suppl: abstr 1501","DOI":"10.1200\/jco.2011.29.15_suppl.1501"},{"issue":"5","key":"1717_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","volume":"21","author":"CB Powell","year":"2011","unstructured":"Powell CB, Chen LM, McLennan J et al (2011) Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 21(5):846\u2013851. https:\/\/doi.org\/10.1097\/IGC.0b013e31821bc7e3","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"1717_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","volume":"16","author":"V Weinberger","year":"2016","unstructured":"Weinberger V, Bednarikova M, Cibula D, Zikan M (2016) Serous tubal intraepithelial carcinoma (STIC)\u2014clinical impact and management. Exp Rev Anticancer Therapy 16(12):1311\u20131321. https:\/\/doi.org\/10.1080\/14737140.2016.1247699","journal-title":"Exp Rev Anticancer Therapy"},{"issue":"1","key":"1717_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","volume":"121","author":"J Kwon","year":"2013","unstructured":"Kwon J, Tinker A, Pansegrau G et al (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121(1):14\u201324. https:\/\/doi.org\/10.1097\/AOG.0b013e3182783c2f","journal-title":"Obstet Gynecol"},{"issue":"S2","key":"1717_CR24","first-page":"296A","volume":"29","author":"S Mahon","year":"2016","unstructured":"Mahon S, McFadden J, Gleeson N, O\u2019Riain C (2016) Would fallopian tube tissue be left behind? Quantitation of tubal-type epithelium within ovary at time of risk reduction salpingo-oophorectomy\u2014implications for ovary conserving strategies. Mod Pathol 29(S2):296A","journal-title":"Mod Pathol"},{"issue":"1","key":"1717_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejogrb.2013.06.030","volume":"170","author":"MW Kamran","year":"2013","unstructured":"Kamran MW, Vaughan D, Crosby D, Wahab NA, Saadeh FA, Gleeson N (2013) Opportunistic and interventional salpingectomy in women at risk\u2014a strategy for preventing pelvic serous cancer (PSC). Eur J Obstet Gynecol Reprod Biol 170(1):251\u2013254. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.06.030","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1717_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","volume":"127","author":"MJ Mingels","year":"2012","unstructured":"Mingels MJ, Roelofsen T, Van der Laak JA et al (2012) Tubal epithelial lesions in alpingo-oophorectomy specimens of BRCA-mutation carriers and controls. Gynecol Oncol 127(1):88\u201393. https:\/\/doi.org\/10.1016\/j.ygyno.2012.06.015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1717_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00432-014-1622-6","volume":"140","author":"J Vorwergk","year":"2014","unstructured":"Vorwergk J (2014) Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol 140(5):859\u2013865. https:\/\/doi.org\/10.1007\/s00432-014-1622-6","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1717_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00404-015-3697-y","volume":"292","author":"M Polcher","year":"2015","unstructured":"Polcher M, Hauptmann S, Fotopoulou C et al (2015) Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO. Arch Gynecol Obstet 292(1):231\u2013234. https:\/\/doi.org\/10.1007\/s00404-015-3697-y","journal-title":"Arch Gynecol Obstet"},{"key":"1717_CR29","unstructured":"Venturella R, Lico D, Borelli M et al (2016) 3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function. Minim Invasive Gynecol 13:S1553\u2013S4650"},{"issue":"1","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","volume":"130","author":"Y Segev","year":"2013","unstructured":"Segev Y, Igbal J, Lubinski J, Hereditary Breast Cancer Study Group et al (2013) The incidence of endometrial cancer in women with BRCA 1 and BRCA 2 mutations: an international prospective cohort study. Gynecol Oncol 130(1):127\u2013131. https:\/\/doi.org\/10.1016\/j.ygyno.2013.03.027","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cncr.27720","volume":"119","author":"KP Pennington","year":"2013","unstructured":"Pennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ, Thornton A, Garcia R, Mutch D, King MC, Goodfellow P, Swisher EM (2013) BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 119(2):332\u2013338. https:\/\/doi.org\/10.1002\/cncr.27720","journal-title":"Cancer"},{"issue":"6","key":"1717_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1471-0528.1997.tb11992.x","volume":"104","author":"WG Mc Cluggage","year":"1997","unstructured":"Mc Cluggage WG, Mc Manus DT, Lioe TF, Hill CM (1997) Uterine carcino-sarcoma in association with tamoxifen treatment. Brit J Obstet Gynaecol 104(6):748\u2013775. https:\/\/doi.org\/10.1111\/j.1471-0528.1997.tb11992.x","journal-title":"Brit J Obstet Gynaecol"},{"issue":"3","key":"1717_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamaoncol.2015.0494","volume":"1","author":"R Chlebowski","year":"2015","unstructured":"Chlebowski R, Rohan T, Manson J et al (2015) Breast cancer after use of oestrogen plus progestin and oestrogen alone: analysis from 2 Women\u2019s Health Initiative Randomised Clinical Trials. JAMA Oncol 1(3):296\u2013305. https:\/\/doi.org\/10.1001\/jamaoncol.2015.0494","journal-title":"JAMA Oncol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-017-1717-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-017-1717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-017-1717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T19:40:45Z","timestamp":1570563645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-017-1717-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s11845-017-1717-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}